PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival
500
about 3 years
18+
1 site in NC
What this study is about
This trial is testing whether a precision oncology navigator and expert review of genomic sequencing can help more patients get treatments that are tailored to their specific cancer. The goal is to see if this approach leads to more people enrolling in clinical trials and improves survival rates.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Blood or tissue samples collection
- 2.Expert Review
- 3.The Precision Oncology Navigation
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Overall Survival in subjects who are eligible for Level 1/2 genome-informed therapy (GIT), Overall survival (OS), The combined rate of orders for Level 1/2 GIT and consent to biomarker-directed clinical trials, The rates of consent to UNC Health biomarker-selective clinical trials
Oncology